Preventive Healthcare Technologies And Services Market Size, Share & Trends Analysis Report By Type (Early Detection & Screening, Chronic Disease Management, Vaccines), By Region, And Segment Forecasts, 2023

The global preventive healthcare technologies and services market size is expected to reach USD 585.6 billion by 2030, registering a CAGR of 11.8% from 2023 to 2030. Key factors driving the market expansion include the growing awareness about preventive measures, which enhance the quality of life, lifespan, and minimize the possible healthcare spending.

The growth of this market is attributed to the adoption of advanced technology and the development of preventive measures, including vaccines, screening & monitoring devices, and smart devices to reduce medical errors. Growth of the market is also fueled by factors such as reducing the birth rate that is resulting in an increase of the geriatric population, which is more prone to chronic diseases.

With the introduction of the Human Development Index (HDI) ratings since 2010, all countries are engaged in the overall development of their country and citizens. Life expectancy has a significant impact on HDI calculations. Governments of the countries have been focusing on improving life expectancy of the people by implementing various programs, including free or affordable vaccination, smoking cessation, and affordable insurance schemes. These programs cause a direct positive impact on preventable technologies and services space.

A large share of preventive healthcare includes early detection and screening technology. This segment pertains to personalized diagnostic techniques, which has captured the largest share owing to the accuracy and availability of the innovative techniques for diagnosis.

Preventive Healthcare Technologies And Services Market Report Highlights

According to data published by the WHO, the percentage of the total vaccinations in the U.S. has been growing. The vaccinations included those funded by the government as well as private purchases.
In 2022, the early detection and screening technologies’ segment captured the largest share. The advantages associated with personalized medicine technologies, such as high accuracy and detection of the possible disease or disorder at an early stage, are mainly attributed to the largest share of the segment.
With the introduction of advanced technology and the growing demand for accurate screening methods, the growth of early detection and screening is expected to be the fastest during the forecast period.
North America dominated the market with the largest revenue share of 40.4% in 2022.
Growing economies and government initiatives are expected to drive the growth of the Asia Pacific region. The segment is expected to witness a lucrative CAGR of over 14.2% during the forecast period.

Chapter 1. Methodology and Scope

1.1. Market Segmentation & Scope
1.1.1. Technology
1.1.2. Regional scope
1.1.3. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Technology outlook
2.2.2. Regional outlook
2.3. Competitive Insights

Chapter 3. Preventive Healthcare Technologies & Services Market Variables, Trends & Scope

3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market driver analysis
3.3.2. Market restraint analysis
3.4. Preventive Healthcare Technologies & Services Market Analysis Tools
3.4.1. Industry Analysis - Porter’s
3.4.1.1. Supplier power
3.4.1.2. Buyer power
3.4.1.3. Substitution threat
3.4.1.4. Threat of new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Technological landscape
3.4.2.3. Economic landscape

Chapter 4. Preventive Healthcare Technologies & Services Market: Type Estimates & Trend Analysis

4.1. Preventive Healthcare Technologies & Services Market: Key Takeaways
4.2. Preventive Healthcare Technologies & Services Market: Movement & Market Share Analysis, 2022 & 2030
4.3. Early Detection & Screening Technologies
4.3.1. Early detection & screening technologies market estimates and forecasts, 2018 to 2030 (USD Billion)
4.3.2. Automated screening
4.3.2.1. Automated screening market estimates and forecasts, 2018 to 2030 (USD Billion)
4.3.3. Personalized medicine
4.3.3.1. Personalized medicine market estimates and forecasts, 2018 to 2030 (USD Billion)
4.3.4. Other advanced screening technologies
4.3.4.1. Other advanced screening technologies market estimates and forecasts, 2018 to 2030 (USD Billion)
4.4. Chronic Disease Management Technologies
4.4.1. Chronic disease management technologies market estimates and forecasts, 2018 to 2030 (USD Billion)
4.4.2. Blood pressure monitors
4.4.2.1. Blood pressure monitors market estimates and forecasts, 2018 to 2030 (USD Billion)
4.4.3. Asthma monitors
4.4.3.1. Asthma monitors market estimates and forecasts, 2018 to 2030 (USD Billion)
4.4.4. Cardiovascular monitors
4.4.4.1. Cardiovascular monitors market estimates and forecasts, 2018 to 2030 (USD Billion)
4.4.5. Glucose monitors
4.4.5.1. Glucose monitors market estimates and forecasts, 2018 to 2030 (USD Billion)
4.5. Vaccines
4.5.1. Vaccines market estimates and forecasts, 2018 to 2030 (USD Billion)
4.5.2. Infectious diseases
4.5.2.1. Infectious diseases market estimates and forecasts, 2018 to 2030 (USD Billion)
4.5.3. Cancer vaccine
4.5.3.1. Cancer vaccine market estimates and forecasts, 2018 to 2030 (USD Billion)
4.5.4. Autism vaccine
4.5.4.1. Autism vaccine market estimates and forecasts, 2018 to 2030 (USD Billion)
4.5.5. Allergy vaccine
4.5.5.1. Allergy vaccine market estimates and forecasts, 2018 to 2030 (USD Billion)
4.5.6. Other new vaccines
4.5.6.1. Other new vaccines market estimates and forecasts, 2018 to 2030 (USD Billion)
4.6. Advanced Technologies to Reduce Errors
4.6.1. Advanced technologies to reduce errors market estimates and forecasts, 2018 to 2030 (USD Billion)
4.6.2. Electronic prescribing
4.6.2.1. Electronic prescribing market estimates and forecasts, 2018 to 2030 (USD Billion)
4.6.3. Clinical decision support system
4.6.3.1. Clinical decision support system market estimates and forecasts, 2018 to 2030 (USD Billion)
4.6.4. Smart infusion pumps
4.6.4.1. Smart infusion pumps market estimates and forecasts, 2018 to 2030 (USD Billion)
4.6.5. Computerized provider order entry system
4.6.5.1. Computerized provider order entry system market estimates and forecasts, 2018 to 2030 (USD Billion)
4.6.6. Smart packaging
4.6.6.1. Smart packaging market estimates and forecasts, 2018 to 2030 (USD Billion)

Chapter 5. Preventive Healthcare Technologies & Services Market: Regional Estimates & Trend Analysis

5.1. Regional Outlook
5.2. Preventive Healthcare Technologies & Services Market by Region: Key Takeaway
5.3. North America
5.3.1. North America market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.3.2. U.S.
5.3.2.1. U.S. market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.3.3. Canada
5.3.3.1. Canada market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.4. Europe
5.4.1. Europe market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.4.2. UK
5.4.2.1. UK market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.4.3. Germany
5.4.3.1. Germany market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.4.4. France
5.4.4.1. France market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.4.5. Italy
5.4.5.1. Italy market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.4.6. Spain
5.4.6.1. Spain market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.4.7. Sweden
5.4.7.1. Sweden market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.4.8. Norway
5.4.8.1. Norway market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.4.9. Denmark
5.4.9.1. Denmark market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.5. Asia Pacific
5.5.1. Asia Pacific market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.5.2. Japan
5.5.2.1. Japan market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.5.3. China
5.5.3.1. China market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.5.4. India
5.5.4.1. India market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.5.5. Australia
5.5.5.1. Australia market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.5.6. Thailand
5.5.6.1. Thailand market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.5.7. South Korea
5.5.7.1. South Korea market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.6. Latin America
5.6.1. Latin America market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.6.2. Brazil
5.6.2.1. Brazil market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.6.3. Mexico
5.6.3.1. Mexico market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.6.4. Argentina
5.6.4.1. Argentina market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.7. MEA
5.7.1. MEA market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.7.2. Saudi Arabia
5.7.2.1. Saudi Arabia market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.7.3. South Africa
5.7.3.1. South Africa market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.7.4. UAE
5.7.4.1. UAE market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.7.5. Kuwait
5.7.5.1. Kuwait market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 6. Competitive Landscape

6.1. Recent Developments & Impact Analysis, By Key Market Participants
6.2. Market Participant Categorization
6.2.1. Myriad Genetics, Inc.
6.2.1.1. Company overview
6.2.1.2. Financial performance
6.2.1.3. Product benchmarking
6.2.1.4. Strategic initiatives
6.2.2. Quest Diagnostics Incorporated
6.2.2.1. Company overview
6.2.2.2. Financial performance
6.2.2.3. Product benchmarking
6.2.2.4. Strategic initiatives
6.2.3. Medtronic
6.2.3.1. Company overview
6.2.3.2. Financial performance
6.2.3.3. Product benchmarking
6.2.3.4. Strategic initiatives
6.2.4. Abbott
6.2.4.1. Company overview
6.2.4.2. Financial performance
6.2.4.3. Product benchmarking
6.2.4.4. Strategic initiatives
6.2.5. Merck & Co., Inc.
6.2.5.1. Company overview
6.2.5.2. Financial performance
6.2.5.3. Product benchmarking
6.2.5.4. Strategic initiatives
6.2.6. GSK plc
6.2.6.1. Company overview
6.2.6.2. Financial performance
6.2.6.3. Product benchmarking
6.2.6.4. Strategic initiatives
6.2.7. Omnicell
6.2.7.1. Company overview
6.2.7.2. Financial performance
6.2.7.3. Product benchmarking
6.2.7.4. Strategic initiatives
6.2.8. MCKESSON CORPORATION
6.2.8.1. Company overview
6.2.8.2. Financial performance
6.2.8.3. Product benchmarking
6.2.8.4. Strategic initiatives

List of Tables

Table 1 List of abbreviations
Table 2 North America preventive healthcare technologies and services market, by type, 2018-2030 (USD Billion)
Table 3 North America preventive healthcare technologies and services market, by region, 2018-2030 (USD Billion)
Table 4 U.S. preventive healthcare technologies and services market, by type, 2018-2030 (USD Billion)
Table 5 Canada preventive healthcare technologies and services market, by type, 2018-2030 (USD Billion)
Table 6 Europe preventive healthcare technologies and services market, by type, 2018-2030 (USD Billion)
Table 7 Europe preventive healthcare technologies and services market, by region, 2018-2030 (USD Billion)
Table 8 Germany preventive healthcare technologies and services market, by type, 2018-2030 (USD Billion)
Table 9 UK preventive healthcare technologies and services market, by type, 2018-2030 (USD Billion)
Table 10 France preventive healthcare technologies and services market, by type, 2018-2030 (USD Billion)
Table 11 Italy preventive healthcare technologies and services market, by type, 2018-2030 (USD Billion)
Table 12 Spain preventive healthcare technologies and services market, by type, 2018-2030 (USD Billion)
Table 13 Sweden preventive healthcare technologies and services market, by type, 2018-2030 (USD Billion)
Table 14 Norway preventive healthcare technologies and services market, by type, 2018-2030 (USD Billion)
Table 15 Denmark preventive healthcare technologies and services market, by type, 2018-2030 (USD Billion)
Table 16 Asia Pacific preventive healthcare technologies and services market, by type, 2018-2030 (USD Billion)
Table 17 Asia Pacific preventive healthcare technologies and services market, by region, 2018-2030 (USD Billion)
Table 18 China preventive healthcare technologies and services market, by type, 2018-2030 (USD Billion)
Table 19 Japan preventive healthcare technologies and services market, by type, 2018-2030 (USD Billion)
Table 20 India preventive healthcare technologies and services market, by type, 2018-2030 (USD Billion)
Table 21 Australia preventive healthcare technologies and services market, by type, 2018-2030 (USD Billion)
Table 22 Thailand preventive healthcare technologies and services market, by type, 2018-2030 (USD Billion)
Table 23 South Korea preventive healthcare technologies and services market, by type, 2018-2030 (USD Billion)
Table 24 Latin America preventive healthcare technologies and services market, by type, 2018-2030 (USD Billion)
Table 25 Latin America preventive healthcare technologies and services market, by region, 2018-2030 (USD Billion)
Table 26 Brazil preventive healthcare technologies and services market, by type, 2018-2030 (USD Billion)
Table 27 Mexico preventive healthcare technologies and services market, by type, 2018-2030 (USD Billion)
Table 28 Argentina preventive healthcare technologies and services market, by type, 2018-2030 (USD Billion)
Table 29 Middle East and Africa preventive healthcare technologies and services market, by type, 2018-2030 (USD Billion)
Table 30 Middle East and Africa preventive healthcare technologies and services market, by region, 2018-2030 (USD Billion)
Table 31 South Africa preventive healthcare technologies and services market, by type, 2018-2030 (USD Billion)
Table 32 Saudi Arabia preventive healthcare technologies and services market, by type, 2018-2030 (USD Billion)
Table 33 UAE preventive healthcare technologies and services market, by type, 2018-2030 (USD Billion)
Table 34 Kuwait preventive healthcare technologies and services market, by type, 2018-2030 (USD Billion)

List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Preventive healthcare technologies and services: market outlook
Fig. 9 Preventive healthcare technologies and services competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 Industry value chain analysis
Fig. 14 Preventive healthcare technologies and services market driver impact
Fig. 15 Preventive healthcare technologies and services market restraint impact
Fig. 16 Preventive healthcare technologies and services market strategic initiatives analysis
Fig. 17 Preventive healthcare technologies and services market: Type movement analysis
Fig. 18 Preventive healthcare technologies and services market: Type outlook and key takeaways
Fig. 19 Early detection & screening technologies market estimates and forecasts, (USD Billion) 2018 - 2030
Fig. 20 Automated screening market estimates and forecasts, 2018-2030 (USD Billion)
Fig. 21 Personalized medicine market estimates and forecasts, 2018-2030 (USD Billion)
Fig. 22 Other advanced screening technologies market estimates and forecasts, 2018-2030 (USD Billion)
Fig. 23 Chronic disease management technologies market estimates and forecasts, 2018-2030 (USD Billion)
Fig. 24 Blood pressure monitors market estimates and forecasts, 2018-2030 (USD Billion)
Fig. 25 Asthma monitors market estimates and forecasts, 2018-2030 (USD Billion)
Fig. 26 Cardiovascular monitors market estimates and forecasts, 2018-2030 (USD Billion)
Fig. 27 Glucose monitors market estimates and forecasts, 2018-2030 (USD Billion)
Fig. 28 Vaccines market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 29 Infectious diseases vaccine market estimates and forecasts, 2018-2030 (USD Billion)
Fig. 30 Cancer vaccine market estimates and forecasts, 2018-2030 (USD Billion)
Fig. 31 Autism vaccine market estimates and forecasts, 2018-2030 (USD Billion)
Fig. 32 Allergy vaccine market estimates and forecasts, 2018-2030 (USD Billion)
Fig. 33 Other new vaccines market estimates and forecasts, 2018-2030 (USD Billion)
Fig. 34 Advanced technologies to reduce error market estimates and forecasts, (USD Billion) 2018 - 2030
Fig. 35 Electronic prescribing market estimates and forecasts, 2018-2030 (USD Billion)
Fig. 36 Clinical decision supports system market estimates and forecasts, 2018-2030 (USD Billion)
Fig. 37 Smart infusion pumps market estimates and forecasts, 2018-2030 (USD Billion)
Fig. 38 Computerized provider order entry system market estimates and forecasts, 2018-2030 (USD Billion)
Fig. 39 Smart packaging and automated prescription formulation and dispensing market estimates and forecasts, 2018-2030 (USD Billion)
Fig. 40 Preventive healthcare technologies and services market: Regional movement analysis
Fig. 41 Preventive healthcare technologies and services market: Regional outlook and key takeaways
Fig. 42 North America market estimates and forecasts, 2018-2030 (USD Billion)
Fig. 43 U.S. market estimates and forecasts, 2018-2030 (USD Billion)
Fig. 44 Canada market estimates and forecasts, 2018-2030 (USD Billion)
Fig. 45 Europe market estimates and forecasts, 2018-2030 (USD Billion)
Fig. 46 UK market estimates and forecasts, 2018-2030 (USD Billion)
Fig. 47 Germany market estimates and forecasts, 2018-2030 (USD Billion)
Fig. 48 France market estimates and forecasts, 2018-2030 (USD Billion)
Fig. 49 Italy market estimates and forecasts, 2018-2030 (USD Billion)
Fig. 50 Spain market estimates and forecasts, 2018-2030 (USD Billion)
Fig. 51 Sweden market estimates and forecasts, 2018-2030 (USD Billion)
Fig. 52 Norway market estimates and forecasts, 2018-2030 (USD Billion)
Fig. 53 Denmark market estimates and forecasts, 2018-2030 (USD Billion)
Fig. 54 Asia Pacific market estimates and forecasts, 2018-2030 (USD Billion)
Fig. 55 Japan market estimates and forecasts, 2018-2030 (USD Billion)
Fig. 56 China market estimates and forecasts, 2018-2030 (USD Billion)
Fig. 57 India market estimates and forecasts, 2018-2030 (USD Billion)
Fig. 58 Australia market estimates and forecasts, 2018-2030 (USD Billion)
Fig. 59 Thailand market estimates and forecasts, 2018-2030 (USD Billion)
Fig. 60 South Korea market estimates and forecasts, 2018-2030 (USD Billion)
Fig. 61 Latin America market estimates and forecasts, 2018-2030 (USD Billion)
Fig. 62 Brazil market estimates and forecasts, 2018-2030 (USD Billion)
Fig. 63 Mexico market estimates and forecasts, 2018-2030 (USD Billion)
Fig. 64 Argentina market estimates and forecasts, 2018-2030 (USD Billion)
Fig. 65 Middle East and Africa. market estimates and forecasts, 2018-2030 (USD Billion)
Fig. 66 Saudi Arabia market estimates and forecasts, 2018-2030 (USD Billion)
Fig. 67 South Africa market estimates and forecasts, 2018-2030 (USD Billion)
Fig. 68 UAE market estimates and forecasts, 2018-2030 (USD Billion)
Fig. 69 Kuwait market estimates and forecasts, 2018-2030 (USD Billion)

Companies Mentioned

Myriad Genetics, Inc.
Quest Diagnostics Incorporated
Medtronic
Abbott
Merck & Co., Inc.
GSK plc
Omnicell
MCKESSON CORPORATION

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	80
Published	October 2023
Forecast Period	2022 - 2030
Estimated Market Value ( USD ) in 2022	$ 243 Billion
Forecasted Market Value ( USD ) by 2030	$ 585.6 Billion
Compound Annual Growth Rate	11.8%
Regions Covered	Global
No. of Companies Mentioned	8

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€5911EUR$5,950USD£4,915GBP
1 - 5 USER LICENSE PDF	The product is a PDF.	This is a 1-5 user license, allowing up to five users have access to the product.	€6904EUR$6,950USD£5,741GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€8891EUR$8,950USD£7,393GBP

Preventive Healthcare Technologies And Services Market Size, Share & Trends Analysis Report By Type (Early Detection & Screening, Chronic Disease Management, Vaccines), By Region, And Segment Forecasts, 2023 - 2030

Preventive Healthcare Technologies And Services Market Report Highlights

Table of Contents

Companies Mentioned

Methodology

Table Information

Preventive Healthcare Technologies And Services Market Report Highlights

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Preventive Healthcare Technologies & Services Market by Type, Model Type, Application - Global Forecast 2025-2030

Preventive Healthcare Technologies And Services Market Analysis & Forecast to 2024-2034

Preventive Healthcare Technologies and Services - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

Preventive Healthcare Technologies and Services Global Market Report 2024

Preventive Healthcare Technologies And Services Market Innovations and Strategic Insights Report - Market Data, Trends, Market Potential, Competitive Analysis and Growth Forecasts (2024 to 2032)